Published in Am J Pathol on November 01, 1995
Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell (2001) 1.56
Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins. Mol Cell Biol (2000) 1.16
Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet (2000) 0.94
Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin. Neoplasia (2011) 0.81
Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity. J Cell Mol Med (2012) 0.80
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (1993) 6.67
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell (1993) 6.29
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol (1993) 3.96
Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol (1994) 3.68
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63
Microtubules containing detyrosinated tubulin are less dynamic. EMBO J (1987) 3.24
A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23
A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci (1992) 3.04
NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med (1990) 2.31
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet (1994) 2.28
Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med (1988) 2.16
Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interaction. Cell Motil (1983) 1.90
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J Cell Biol (1992) 1.89
Membrane-actin microfilament connections: an increasing diversity of players related to band 4.1. Curr Opin Cell Biol (1994) 1.86
Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet (1994) 1.84
Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci U S A (1993) 1.81
The unlabeled antibody method. Contrasting color staining of paired pituitary hormones without antibody removal. J Histochem Cytochem (1979) 1.72
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet (1994) 1.63
Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet (1994) 1.62
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet (1992) 1.62
The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol (1989) 1.34
Epitope prediction and confirmation for the human androgen receptor: generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochim Biophys Acta (1991) 1.24
Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med (1986) 1.21
An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem (1994) 1.16
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet (1994) 1.13
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet (1994) 1.07
Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet (1994) 1.03
Ocular findings associated with neurofibromatosis type II. Ophthalmology (1992) 1.02
The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet (1994) 1.01
Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene (1993) 0.99
Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene (1994) 0.94
The dot immunobinding assay. Methods Enzymol (1986) 0.93
Ocular fundus in neurofibromatosis type 2. Br J Ophthalmol (1993) 0.90
Isolation and culture of human intestinal smooth muscle cells. Proc Soc Exp Biol Med (1984) 0.88
Clinical and genetic patterns of neurofibromatosis 1 and 2. Br J Ophthalmol (1993) 0.87
The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene (1995) 0.86
Monoclonal antibodies to a human prostate antigen. Cancer Res (1982) 0.82
Keratohyalin, trichohyalin and keratohyalin-trichohyalin hybrid granules: an overview. J Dermatol (1992) 0.81
Lysosomal localization of secretory prostatic acid phosphatase in human hyperplastic prostate epithelium. Urol Res (1986) 0.77
Presence and localization of proteins immunologically related to erythrocyte protein 4.1 in human skin. Histochemistry (1991) 0.77
An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues. J Biochem (1994) 0.77
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
The structure of the vimentin gene. Cell (1983) 2.60
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol (1991) 2.54
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci U S A (1989) 2.54
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol (2007) 2.26
Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol (1999) 2.06
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol (1994) 1.94
Evolution of eye lens crystallins: the stress connection. Trends Biochem Sci (1989) 1.86
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res (2001) 1.86
Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol (1993) 1.82
Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer (1991) 1.81
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res (2001) 1.70
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst (2001) 1.63
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
Alternative splicing of the human Rab6A gene generates two close but functionally different isoforms. Mol Biol Cell (2000) 1.52
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam. Urology (2006) 1.51
Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry (2002) 1.50
Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam. J Natl Cancer Inst (2003) 1.46
Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene (1995) 1.44
The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion. J Pathol (2006) 1.40
Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet (1992) 1.38
MN1 overexpression is an important step in the development of inv(16) AML. Leukemia (2007) 1.35
The lens protein alpha A-crystallin of the blind mole rat, Spalax ehrenbergi: evolutionary change and functional constraints. Proc Natl Acad Sci U S A (1987) 1.31
Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol (2001) 1.30
Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol (1996) 1.29
Transmission of methicillin-resistant Staphylococcus aureus to household contacts. J Clin Microbiol (2009) 1.27
Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum Mol Genet (1997) 1.27
Complete structure of the hamster alpha A crystallin gene. Reflection of an evolutionary history by means of exon shuffling. J Mol Biol (1985) 1.27
PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL. Mol Biol Cell (1998) 1.24
Epitope prediction and confirmation for the human androgen receptor: generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochim Biophys Acta (1991) 1.24
Organization, structure and expression of murine interferon alpha genes. Nucleic Acids Res (1985) 1.24
Sites required for GltC-dependent regulation of Bacillus subtilis glutamate synthase expression. J Bacteriol (1995) 1.24
Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab (2001) 1.22
Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem (1991) 1.20
Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis (1999) 1.20
Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components. Mod Pathol (2000) 1.18
The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol (2000) 1.18
The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy. J Urol (1997) 1.16
Detection of factor VIII/coagulant antigen in human liver tissue. Nature (1983) 1.16
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. J Pathol (2007) 1.14
Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Urol Res (1990) 1.14
The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL. Eur J Cell Biol (2000) 1.11
Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry (1992) 1.08
Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology (1989) 1.08
Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer. Prostate (1997) 1.07
Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol (1996) 1.07
Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183). Hum Genet (1995) 1.06
Regional localization of over 300 loci on human chromosome 22 using a somatic cell hybrid mapping panel. Genomics (1996) 1.05
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. J Urol (2000) 1.05
Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet (2000) 1.04
Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle. Int J Parasitol (1999) 1.03
The neuronal nitric oxide synthase PDZ motif binds to -G(D,E)XV* carboxyterminal sequences. FEBS Lett (1997) 1.03
An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum Pathol (1993) 1.03
Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol (1994) 1.02
Post-irradiation thymocyte regeneration after bone marrow transplantation. I. Regeneration and quantification of thymocyte progenitor cells in the bone marrow. Cell Tissue Kinet (1981) 0.98
Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene (1988) 0.97
Localization of factor VIII-procoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. Blood (1986) 0.97
Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol (1995) 0.97
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol (2005) 0.97
Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. Oncogene (1991) 0.96
Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry (1993) 0.96
Phenotypic and genotypic analysis of large-cell lymphomas, formerly classified as true histiocytic lymphoma: identification of an unusual group of tumors. Leuk Res (1990) 0.95
Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer (1999) 0.95
Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol (2001) 0.95
An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in a dialysis method. J Immunol Methods (1990) 0.95
Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology (2005) 0.95
Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer (1995) 0.94
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml). Prostate (2001) 0.94
Reconstitution of the thymus dependent area in the spleen of lethally irradiated mice. A light and electron microscopical study of the T-cell microenvironment. Cell Tissue Res (1974) 0.94
Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol (2000) 0.94
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res (1997) 0.94
Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation. Cancer Res (2000) 0.94
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol (1990) 0.93
Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene (1986) 0.93
Interferon expression in the testes of transgenic mice leads to sterility. J Biol Chem (1988) 0.93
Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet (1990) 0.92
Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest (1997) 0.92
Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol (1996) 0.92
Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol (1998) 0.92
Isolation and characterization of 25 unique DNA markers for human chromosome 22. Genomics (1993) 0.92
Lambda-crystallin, a major rabbit lens protein, is related to hydroxyacyl-coenzyme A dehydrogenases. J Biol Chem (1988) 0.92
Universal Linkage System: versatile nucleic acid labeling technique. Expert Rev Mol Diagn (2001) 0.92
No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. Br J Cancer (1991) 0.92
Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood (1984) 0.92
Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue. Int J Biol Markers (2001) 0.91
Migration of B lymphocytes in lymphoid organs of lethally irradiated, thymocyte-reconstituted mice. Cell Tissue Res (1980) 0.91
Receptor-like protein tyrosine phosphatases: alike and yet so different. Mol Biol Rep (1997) 0.91
An immunohistologic study of the epithelial and lymphoid components of six thymomas. Hum Pathol (1985) 0.91
The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J Neuroimmunol (1994) 0.90
Purification of rat pluripotent hemopoietic stem cells. Stem Cells (1982) 0.90